🇺🇸 Imidazolyl ethanamide pentandioic acid in United States

2 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 2

Most-reported reactions

1. Maternal Exposure During Pregnancy — 1 report (50%)
2. Pneumonia — 1 report (50%)

Source database →

Frequently asked questions

Is Imidazolyl ethanamide pentandioic acid approved in United States?

Imidazolyl ethanamide pentandioic acid does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Imidazolyl ethanamide pentandioic acid in United States?

Valenta Pharm JSC is the originator. The local marketing authorisation holder may differ — check the official source linked above.